- Poster presentation
- Open access
- Published:
Description of a case of late-onset cryopyrin-associated periodic syndrome due to low-level somatic NLRP3 mosaicism
Pediatric Rheumatology volume 13, Article number: P60 (2015)
Introduction
Cryopyrin-associated periodic syndromes (CAPS) usually present in early childhood as an urticaria-like skin rash associated with an increased inflammatory response, with additional manifestations (i.e. arthropathy, AA amyloidosis or deafness) typically restricted to certain phenotypes. CAPS are caused by dominantly inherited or de novo gain-of-function NLRP3 mutations. The introduction of next-generation sequencing (NGS) into clinics has revealed the important role of somatic NLRP3 mosaicism in these syndromes by means of its detection in a high proportion of patients who were apparently mutation-negative by Sanger sequencing. Thus, NGS technologies are becoming essential for routinely identifying the genetic cause of the suspected autoinflammatory disease.
Objective
To describe a Spanish patient with CAPS that start in adulthood in whom molecular analyses detected a novel NLRP3 mutation as a somatic mutation.
Patients and methods
Genomic DNA was extracted from peripheral blood. The analysis of the six most common genes associated with autoinflammatory diseases (MEFV, TNFRSF1A, MVK, NLRP3, NOD2 and PSTPIP1) was performed by NGS. Additional molecular studies of somatic NLRP3 mosaicism were performed by targeted deep sequencing (TDS).
Results
The patient is a 63 year-old Spanish male who presented with a generalized urticarial rash, a gradually worsening oligoarthritis at wrists, elbows and knees, and a moderate bilateral sensorineural hypoacusia starting in his 50s. Laboratory results showed a marked leucocytosis, neutrophilia and increased inflammatory markers without evidence of circulating autoantibodies. Multiple therapeutic approaches including NSAID, corticosteroids, methotrexate and colchicine result in poor or partial responses. Screening of autoinflammatory-associated genes identified a novel NLRP3 variant (c.1906C>G; p.Gln636Glu) with an allele frequency of 12.2% (coverage: 738x). We hypothesized that this variant could be a somatic NLRP3 mutation. TDS confirmed the somatic NLRP3 mosaicism at 18.4 % (mean of triplicates; mean coverage: 6225x). Additional analyses showed that this variant has never been reported in public databases, that is located on a highly evolutionary conserved amino acid residue and that is predicted to be possibly damaging by PolyPhen-2 algorithm. Additional functional and genetic studies are currently ongoing.
Conclusions
We herein describe the case of a patient with a clinical picture compatible with MWS, with the exception of a late onset of the disease, who carries a somatic NLRP3 mosaicism. Our findings highlight the diagnostic utility of NGS technologies in detecting low-level somatic gene mosaicism and support its use as a routine genetic screening tool.
Consent to publish
Written informed consent for publication of their clinical details was obtained from the patient/parent/guardian/relative of the patient.
Author information
Authors and Affiliations
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Mensa-Vilaro, A., Bosque-Peralta, M., Gonzalez-Roca, E. et al. Description of a case of late-onset cryopyrin-associated periodic syndrome due to low-level somatic NLRP3 mosaicism. Pediatr Rheumatol 13 (Suppl 1), P60 (2015). https://doi.org/10.1186/1546-0096-13-S1-P60
Published:
DOI: https://doi.org/10.1186/1546-0096-13-S1-P60